Rola Hammoud
Rola Hammoud is a postdoctoral scientist in Dr. Daniel Drucker’s lab at Mount Sinai Hospital, where she is researching the gut hormone GIP in relation to tirzepatide, a dual-action drug for diabetes and weight loss. With a background in nutritional science, she emphasizes the complex physiological processes influencing weight loss and appetite control, challenging the notion that these issues are solely a matter of willpower.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 8.00 | 0.09% | +0% | 38,005,238 | 35,223 | $1,700,000 | 1,576$ |
| Totals | 1 | 38,005,238 | 35,223 | $1,700,000 | 1,576$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Dr. Rola Hammoud is studying the mechanism of the gut hormone GIP, which works with GLP-1 in tirzepatide.
8